Detalhe da pesquisa
1.
Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa.
Blood
; 141(12): 1402-1410, 2023 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36375125
2.
Stroke Prevention with Hydroxyurea Enabled through Research and Education: A Phase 2 Primary Stroke Prevention Trial in Sub-Saharan Africa.
Acta Haematol
; 146(2): 95-105, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-35977532
3.
Trends in sickle cell trait and disease screening in the Republic of Uganda, 2014-2019.
Trop Med Int Health
; 26(1): 23-32, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33151598
4.
AnemoCheck-LRS: an optimized, color-based point-of-care test to identify severe anemia in limited-resource settings.
BMC Med
; 18(1): 337, 2020 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33190639
5.
Surveillance for sickle cell disease, United Republic of Tanzania.
Bull World Health Organ
; 98(12): 859-868, 2020 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33293746
6.
Robust clinical and laboratory response to hydroxyurea using pharmacokinetically guided dosing for young children with sickle cell anemia.
Am J Hematol
; 94(8): 871-879, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31106898
7.
Sickle cell screening in Uganda: High burden, human immunodeficiency virus comorbidity, and genetic modifiers.
Pediatr Blood Cancer
; 66(8): e27807, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31094093
8.
Realizing effectiveness across continents with hydroxyurea: Enrollment and baseline characteristics of the multicenter REACH study in Sub-Saharan Africa.
Am J Hematol
; 93(4): 537-545, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29318647
9.
Characteristics of a rapid, point-of-care lateral flow immunoassay for the diagnosis of sickle cell disease.
Am J Hematol
; 91(2): 205-10, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26537622
10.
Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia.
Blood
; 121(16): 3237-45, 2013 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-23422753
11.
Epigenetic and molecular profiles of erythroid cells after hydroxyurea treatment in sickle cell anemia.
Blood
; 118(20): 5664-70, 2011 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-21921042
12.
Genetic predictors for stroke in children with sickle cell anemia.
Blood
; 117(24): 6681-4, 2011 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-21515823
13.
Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes.
Am J Hematol
; 88(7): 571-6, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23606168
14.
Hydroxycarbamide alters erythroid gene expression in children with sickle cell anaemia.
Br J Haematol
; 157(2): 240-8, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22360576
15.
A novel laboratory technique demonstrating the influences of RHD zygosity and the RhCcEe phenotype on erythrocyte D antigen expression.
Am J Hematol
; 87(3): 266-71, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22121029
16.
Genotoxicity associated with hydroxyurea exposure in infants with sickle cell anemia: results from the BABY-HUG Phase III Clinical Trial.
Pediatr Blood Cancer
; 59(2): 254-7, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22012708
17.
Chromosome damage and repair in children with sickle cell anaemia and long-term hydroxycarbamide exposure.
Br J Haematol
; 154(1): 134-40, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21542824
18.
Operational analysis of the national sickle cell screening programme in the Republic of Uganda.
Afr J Lab Med
; 10(1): 1303, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34522631
19.
Hydroxyurea Pharmacokinetics in Pediatric Patients After Total Pancreatectomy With Islet Autotransplantation.
J Clin Pharmacol
; 61(4): 547-554, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33029796
20.
Assessment of genotoxicity associated with hydroxyurea therapy in children with sickle cell anemia.
Mutat Res
; 698(1-2): 38-42, 2010 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-20230905